ONY Biotech
6 News & Press Releases found

ONY Biotech news

Dr. James Cummings has been an unofficial member of the ONY Biotech family since 1989, when he first started working at the Children’s Hospital of Buffalo.

This month, it becomes official, as Dr. Cummings joins the ONY Biotech team as Chief Medical Officer, and the founder of the company and former Chief Medical Officer, Dr. Edmund Egan, steps into the role of Chief Scientific Officer.

“Back in 1989, two things struck me from the start,” Cummings said,

<
Jan. 31, 2023

Earlier this year, our founder and longtime Chief Medical Officer, Dr. Edmund Egan—known by many as Ted—announced his retirement after more than 37 years with the company.

Dr. Egan was one of five scientists that founded ONY Biotech, then ONY, Inc., in 1985 in hopes of developing a lung surfactant to treat premature infants born with respiratory distress syndrome, known as RDS.

A few years later, in 1988, Dr. Egan became the sole owner of ONY, and a decade later, I

Oct. 20, 2022

For little lungs everywhere, the families that love them, and the neonatologists who care for them, there’s news coming out of ONY Biotech, a family-focused neonatology pharmaceutical company.

Today, ONY Biotech announced the results of a clinical trial on its aerosolized surfactant for newborns with respiratory distress syndrome (RDS), a disorder caused by lack of su

Nov. 2, 2020

It has become clear in the past few weeks we are facing an unprecedented challenge whose impact is being felt worldwide. We recognize we are a critical component in the treatment of NICU babies and are committed to ensuring that our customers continue to receive access to Infasurf® (calfactant), while also observing the wellbeing of our community.

What We Are Doing
Infasurf® is sourced, manufactured and packaged exclusively in the United

Mar. 17, 2020

On May 9th, 2019, local radio stations Kiss 98.5 and WBEN hosted the annual Kiss Cares for Kids/ WBEN Radiothon to benefit Oishei Children’s Hospital. The entire radiothon raised over $208,000, surpassing the original $173,000 goal that would enable the hospital to purchase a new ENT Tower.

May. 12, 2019